LOSARTAN Drug Patent Profile

Which patents cover Losartan, and what generic alternatives are available?

Losartan is a drug marketed by Aiping Pharm Inc, Alembic Pharms Ltd, Apotex, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, Zydus Pharms Usa Inc, and Teva Pharms. and is included in forty-one NDAs.

The generic ingredient in LOSARTAN is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.

Summary for LOSARTAN

US Patents:	0
Applicants:	25
NDAs:	41
Drug Prices:	Drug price information for LOSARTAN
Drug Sales Revenues:	Drug sales revenues for LOSARTAN
DailyMed Link:	LOSARTAN at DailyMed

See drug prices for LOSARTAN

See drug sales revenues for LOSARTAN

US Patents and Regulatory Information for LOSARTAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa Inc	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	078243-003	Oct 6, 2010	AB	RX	No	No
Torrent Pharms	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	090528-002	Oct 6, 2010		DISCN	No	No
Ipca Labs Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	200290-002	Aug 30, 2013		DISCN	No	No
Macleods Pharms Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	202230-002	May 30, 2012	AB	RX	No	No
Macleods Pharms Ltd	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	202289-002	Aug 9, 2012	AB	RX	No	No
Granules	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	218015-002	Sep 29, 2023		DISCN	No	No